CD-Genomics proprietary GenSeqTM offers genetic testing portfolio which is based on a technology that assesses a complex but specific set of sites on the human genome -- single nucleotide polymorphisms (SNPs) – that determine an individual's likelihood of disease.

Our GenSeqTM Disease Susceptibility Panel is a superior choice for the test of susceptibility gene to disease. Our genetic services are well-established, fast, accurate, valid, and usually provide high reliable and economically practical health care.

By determining your carrier status for mutations linked to 34 common diseases susceptibility, we'll give you and your family knowledge to help you prepare for the future. More information, please visit the website: http://www.cd-genomics.com/Risk-Forecast-of-Disease.html